Atlas Trials

Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma

Clinical trial NCT00358319 · TERMINATED

Trial details

NCT number
NCT00358319
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Malignant Melanoma
Start date
2005-03-01
Primary completion
2007-04-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.